Abstract
Bacteria encode diverse mechanisms for mediating interbacterial antagonism through the exchange of toxic effector proteins. Although the structure, function, and regulation of these pathways has been well established for many organisms, an understanding of their ecological and evolutionary dynamics lags behind. Type VI secretion systems (T6SS) deliver effectors between competing Gram-negative bacteria, including among mammalian gut Bacteroidales, resulting in the evolution of elaborate defense mechanisms that protect against T6SS attack. One such mechanism is the recombinase-associated acquired interbacterial defence (rAID) system, which harbors arrays of orphan immunity genes that diverge in sequence from T6SS-associated cognate immunity genes. It is not known if such sequence divergence impacts rAID orphan immunity function, or how rAID distribution across microbiomes relates to the T6SS. Here, we show that divergent rAID orphan immunity factors that possess dual SUKH domains allow bacteria to survive intoxication by cognate effectors. Such protection is due to high affinity protein-protein interactions between orphan immunity and effector that are comparable to that of cognate effector-immunity. Unlike other examples of T6SS effector-immunity interactions, we find that the binding interface is comprised of electrostatic interactions with a high degree of redundancy underlying its protective capacity. Finally, we quantify orphan immunity and effector gene abundance and dynamics across human gut metagenomes, revealing patterns of co-occurrence indicative of positive selection. Population genetic analyses of longitudinal data suggests that orphan immunity genes accumulate non-synonymous mutations that lie at the predicted protein interface. Together, our findings establish rAID orphan immunity genes as important bacterial fitness determinants in the human gut.
Competing Interest Statement
The authors have declared no competing interest.
Funder Information Declared
National Institutes of HealthNational Institutes of Health, https://ror.org/01cwqze88, P20-GM113132, P30CA023108, S10OD030242, R00GM129874, R35GM142685, T32AI007519
David Braley Center for Antibiotic DiscoveryDavid Braley Center for Antibiotic Discovery, ,
Burroughs Wellcome FundBurroughs Wellcome Fund, https://ror.org/01d35cw23,
Canada Research ChairsCanada Research Chairs, https://ror.org/0517h6h17,